Company Performance: LPCN's revenue, earnings, and pipeline progress directly impact investor confidence. Positive clinical trial results or successful product launches can drive the stock price higher.

Market Sentiment: Overall market conditions and investor risk appetite influence stock valuations. A bullish market might lift LPCN, while a bearish one could pressure it downwards.

Regulatory Decisions: FDA approvals or rejections of LPCN's drugs are major catalysts. Approval news often triggers significant price jumps, while rejection can lead to declines.

Competition: The competitive landscape in the pharmaceutical industry affects LPCN's market share and profitability. New competing drugs can negatively affect the price.

Economic Conditions: Economic factors like interest rates and inflation can indirectly affect pharmaceutical companies and their stock values.

News & Events: Major news releases, industry conferences, and company-specific announcements can all impact the stock price in the short term.